Showing results (71-80 of 96) with videos related to
Sort By:
Pageof 10
Pathogens (Basel, Switzerland)|December 2, 2014
Chemoresistance to Valproate Treatment of Bovine Leukemia Virus-Infected Sheep; Identification of Improved HDAC InhibitorsNicolas Gillet, Fabian Vandermeers, Alix de Brogniez, et al.Viruses|October 14, 2011
Preventive and therapeutic strategies for bovine leukemia virus: lessons for HTLVSabrina M Rodríguez, Arnaud Florins, Nicolas Gillet, et al.Frontiers in Immunology|April 7, 2023
Excess of blood eosinophils prior to therapy correlates with worse prognosis in mesotheliomaMégane Willems, Arnaud Scherpereel, Eric Wasielewski, et al.Molecular Therapy. Nucleic Acids|June 5, 2023
Specific Florent Porquet, Lin Weidong, Kévin Jehasse, et al.Proceedings of the National Academy of Sciences of the United States of America|July 12, 2005
Valproate activates bovine leukemia virus gene expression, triggers apoptosis, and induces leukemia/lymphoma regression in vivoAmine Achachi, Arnaud Florins, Nicolas Gillet, et al.Blood|August 25, 2007
Histone deacetylase mediated transcriptional activation reduces proviral loads in HTLV-1 associated myelopathy/tropical spastic paraparesis patientsAgnès Lezin, Nicolas Gillet, Stéphane Olindo, et al.Frontiers in Immunology|August 29, 2022
A safe and effective vaccine against bovine leukemia virusGuillermo Suárez Archilla, Gerónimo Gutiérrez, Cecilia Camussone, et al.Proceedings of the National Academy of Sciences of the United States of America|April 22, 2004
Suppression of tumor growth and cell proliferation by p13II, a mitochondrial protein of human T cell leukemia virus type 1Micol Silic-Benussi, Ilaria Cavallari, Tatiana Zorzan, et al.Journal of Virology|September 16, 2006
Peripheral blood B-cell death compensates for excessive proliferation in lymphoid tissues and maintains homeostasis in bovine leukemia virus-infected sheepChristophe Debacq, Nicolas Gillet, Becca Asquith, et al.Frontiers in Bioscience (Scholar Edition)|June 2, 2009
Gene activation therapy: from the BLV model to HAM/TSP patientsAgnes Lezin, Stephane Olindo, Gildas Belrose, et al.Pageof 10